WALD · Waldencast plc
Substantial doubt about the company's ability to continue as a going concern.
“There is no guarantee that the Company will be able to consummate a Business Combination within the Combination Period, which raises substantial doubt about the Company's ability to continue as a going concern until the earlier of the consummation of the Business Combination or the date the Company is required to liquidate.”View the 10-Q filed May 16, 2022
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Chart any reported metric, KPI or segment over time — the full statement history lives here
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| $272.07M | $273.87M | $218.14M | $142.47M | — | |
| $89.05M | $82.12M | $76.56M | $55.04M | — | |
| $183.02M | $191.74M | $141.58M | $87.44M | — | |
| 67.27% | 70.01% | 64.9% | 61.37% | — | |
| — | — | $3.2M | $6.09M | — | |
| $247.98M | $245.3M | $220.31M | $82.97M | — | |
| — | — | $56.7M | $13.5M | — | |
| — | — | — | $0 | — | |
| $400.56M | $250.33M | $223.51M | $89.06M | — | |
| -$217.54M | -$58.58M | -$81.93M | -$1.63M | -$9.13M | |
| -79.96% | -21.39% | -37.56% | -1.14% | — | |
| — | — | — | -$1.63M | — | |
| — | $17.16M | $18.91M | $11.12M | — | |
| — | — | — | — | $52.05K | |
| -$44.71M | $10.05M | -$31.01M | -$8.35M | -$5.29M | |
| -$262.25M | -$48.54M | -$112.94M | -$9.97M | — | |
| -$14.19M | $110K | -$6.98M | $9.6M | — | |
| -$229.75M | -$42.44M | -$89.98M | -$19.58M | -$14.43M | |
| -84.44% | -15.5% | -41.25% | -13.74% | — | |
| -$18.31M | -$6.21M | -$15.99M | $0 | — | |
| -$229.75M | -$42.44M | -$89.98M | -$19.58M | — | |
| -$230.38M | -$42.05M | -$90.1M | -$19.61M | — | |
| USD/shares | -$2.01 | -$0.39 | -$0.99 | -$2.45 | — |
| USD/shares | -$2.01 | -$0.39 | -$0.99 | -$2.45 | — |
| shares | 114.07M | 109.3M | 91.16M | 8M | — |
| shares | 114.07M | 109.3M | 91.16M | 8M | — |
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2023: $2M in dividends.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
Peer medians compare against the 13 similar-size Household & Personal Products companies (of 28 listed).
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2021 |
|---|---|---|---|---|
| Obagi Skincare | $161,627,000 | $149,266,000 | $117,651,000 | — |
| Milk Makeup | $110,444,000 | $124,602,000 | $100,487,000 | $142,472,000 |
By Geography (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| North America | $211,972,000 | $202,261,000 | $154,357,000 | $79,122,000 | $64,040,000 |
| United States | $204,500,000 | $192,600,000 | $145,300,000 | $76,700,000 | $63,400,000 |
| Rest of the World | $56,212,000 | $67,108,000 | $58,759,000 | $57,637,000 | $24,484,000 |
| China | — | — | — | $16,200,000 | — |
| Vietnam | — | — | — | $18,600,000 | — |
By Product & Service (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Product | $268,184,000 | $269,369,000 | $213,116,000 | $136,759,000 | $88,524,000 |
| Royalty | $3,887,000 | $4,499,000 | $5,022,000 | $5,713,000 | $5,904,000 |